NovoCure (NVCR) Long-Term Debt Repayments (2018 - 2025)
NovoCure recorded quarterly Long-Term Debt Repayments of $560.9 million in Q4 2025, up 4244.03% quarter-over-quarter from $12.9 million in Q2 2024.
NovoCure's Long-Term Debt Repayments history runs 8 years deep, the most recent figure standing at $560.9 million for Q4 2025.
- In Q4 2025, Long-Term Debt Repayments changed N/A year-over-year to $560.9 million; the TTM figure through Mar 2026 stood at $560.9 million (up 4244.03% YoY), while the FY2025 annual figure was $560.9 million, up 4244.03% from the prior year.
- Long-Term Debt Repayments came in at $560.9 million for Q4 2025 at NovoCure, up from $12.9 million in the prior quarter.
- In the past five years, Long-Term Debt Repayments ranged from a high of $560.9 million in Q4 2025 to a low of $3000.0 in Q2 2023.
- A 5-year average of $47.8 million and a median of $7000.0 in 2021 frame the typical range for Long-Term Debt Repayments.
- Across the five-year window, Long-Term Debt Repayments slumped 100.0% in 2021 and soared 430333.33% in 2024, its largest moves.
- NovoCure's Long-Term Debt Repayments stood at $7000.0 in 2021, then changed by 0.0% to $7000.0 in 2022, then plunged by 57.14% to $3000.0 in 2023, then jumped by 430333.33% to $12.9 million in 2024, then surged by 4244.03% to $560.9 million in 2025.
- According to Business Quant data, Long-Term Debt Repayments over the past three periods registered $560.9 million, $12.9 million, and $3000.0 for Q4 2025, Q2 2024, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.00 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 560.95 Mn |
| Dec 31, 2025 | 560.95 Mn |
| Jun 30, 2024 | 12.91 Mn |
| Jun 30, 2024 | 12.91 Mn |
| Jun 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Dec 31, 2022 | 7,000.00 |
| Dec 31, 2022 | 7,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Jun 30, 2022 | 7,000.00 |
| Jun 30, 2022 | 7,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 6,000.00 |
| Sep 30, 2021 | 6,000.00 |
| Jun 30, 2021 | 7,000.00 |
| Jun 30, 2021 | 7,000.00 |
| Mar 31, 2021 | 6,000.00 |
| Mar 31, 2021 | 6,000.00 |
| Dec 31, 2020 | 6,000.00 |
| Dec 31, 2020 | 6,000.00 |
| Sep 30, 2020 | 150.01 Mn |
| Sep 30, 2020 | 150.01 Mn |
| Jun 30, 2020 | 7,000.00 |
| Jun 30, 2020 | 7,000.00 |
| Mar 31, 2020 | 8,000.00 |
| Mar 31, 2020 | 8,000.00 |
| Dec 31, 2019 | 8,000.00 |
| Dec 31, 2019 | 8,000.00 |
| Sep 30, 2019 | 7,000.00 |
| Sep 30, 2019 | 7,000.00 |
| Jun 30, 2019 | 8,000.00 |
| Jun 30, 2019 | 8,000.00 |
| Mar 31, 2019 | 8,000.00 |
| Mar 31, 2019 | 8,000.00 |
| Dec 31, 2018 | 21,000.00 |
| Dec 31, 2018 | 21,000.00 |
| Sep 30, 2018 | 22,000.00 |
| Sep 30, 2018 | 22,000.00 |
| Mar 31, 2018 | 100.00 Mn |
| Mar 31, 2018 | 100.00 Mn |